Surgical Science Sweden AB (SUSRF) Income Statement
Surgical Science Sweden AB Income Statement
Last quarter (Q2 2026), Surgical Science Sweden AB's total revenue was $254.52M, an increase of 21.69% from the same quarter last year. In Q2, Surgical Science Sweden AB's net income was $20.85M. See Surgical Science Sweden AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 992.34M | $ 884.09M | $ 882.85M | $ 802.54M | $ 366.78M | |
| $ 576.90M | $ 597.90M | $ 612.88M | $ 531.52M | $ 265.94M | |
| $ 467.94M | $ 453.58M | $ 423.73M | $ 368.98M | $ 209.42M | |
| Depreciation and Amortization | $ 83.37M | $ 60.51M | $ 55.61M | $ 51.59M | $ 33.52M |
| $ 192.34M | $ 224.29M | $ 324.53M | $ 279.24M | $ 122.27M | |
| $ 108.97M | $ 144.32M | $ 189.15M | $ 162.54M | $ 88.75M | |
| $ -8.83M | $ 13.77M | $ 79.11M | $ 45.64M | $ -22.95M | |
| $ 100.14M | $ 158.09M | $ 268.26M | $ 208.17M | $ 65.80M | |
| $ 66.82M | $ 131.65M | $ 233.97M | $ 187.97M | $ 86.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.31 | $ 2.58 | $ 4.59 | $ 3.70 | $ 2.03 |
| Diluted EPS | $ 1.31 | $ 2.58 | $ 4.59 | $ 3.69 | $ 2.02 |
| Weighted Average Shares Outstanding | 51.03M | 51.03M | 50.93M | 50.80M | 42.49M |
| Weighted Average Shares Outstanding (Diluted) | 51.03M | 51.03M | 50.94M | 50.91M | 42.67M |
Currency in SEK